IP Library › Assignment 024584/0082
Patent Assignment
Reel/Frame 024584/0082

Merger

Recorded: 2010-06-23 Pages: 9
Assignors
APEX MERGER SUB, INC.
Executed: 2009-04-17
CV THERAPEUTICS, INC.
Executed: 2009-04-17
Assignee
GILEAD PALO ALTO, INC.
333 LAKESIDE DR., FOSTER CITY, CALIFORNIA, 94404
Covered Properties (2)
Quinazolinone Derivatives as Aldh-2 Inhibitors
Patent: 7,951,813 →
Application: 12/062,431 →
Publication: US 2008/0249116
Quinazolinone Derivatives as Aldh-2 Inhibitors
Application: 60/910,329 →
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 25, 2010
From: KEUNG, WING MING; TAO, GUOXIN
To: THE ENDOWMENT FOR RESEARCH IN HUMAN BIOLOGY, INC.
Reel/Frame 023837/0487 →
Assignment of Assignor's Interest Jun 8, 2010
From: ZABLOCKI, JEFF; ABELMAN, MATTHEW; ORGAN, MICHAEL
To: GILEAD PALO ALTO, INC.
Reel/Frame 024503/0740 →
Assignment of Assignor's Interest Jan 24, 2011
From: GILEAD PALO ALTO, INC.
To: GILEAD SCIENCES, INC.
Reel/Frame 025687/0519 →
Assignment of Assignor's Interest Jun 23, 2017
From: GILEAD SCIENCES, INC.
To: AMYGDALA NEUROSCIENCES, INC.
Reel/Frame 042802/0346 →